Working… Menu

A Study of LY3471851 in Participants With Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04119557
Recruitment Status : Completed
First Posted : October 8, 2019
Last Update Posted : August 11, 2021
Nektar Therapeutics
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 21, 2021
Actual Study Completion Date : July 21, 2021